Regarding long-term variations in serum KL-6 levels, Awano et al. and Xue et al. [14,30] observed persistently high serum KL-6 levels even after pneumonia resolution, particularly in patients who developed fibrotic interstitial lung disease [28,29]. This evidence concerns the gene MUC1 and susceptibility to pneumonia measurement.